Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements (FOAs) are listed here. Find amendments inside the FOAs. Subscribe for Email Updates for our opportunities. Also see NIAID Contract Solicitations or Find a Foundation or Other Funding Source outside NIH.

145 Results
Title Activity Code Posting Date Sort ascending Expiration Date
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)- PAR-19-351 R21 August 20, 2019 September 08, 2020
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)- PAR-19-347 R03 August 16, 2019 July 17, 2022
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-346 R21 August 16, 2019 September 08, 2022
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)- RFA-HL-20-030 UG3/UH3 August 14, 2019 October 19, 2019
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed- PAR-19-333 SB1 August 05, 2019 April 06, 2022
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)- PAR-19-307 R01 June 28, 2019 January 15, 2022
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)- PAR-19-296 DP2 June 07, 2019 October 14, 2021
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)- RFA-AI-19-042 U01 May 30, 2019 September 17, 2019
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)- RFA-AI-19-043 U19 May 30, 2019 September 17, 2019
Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (SBIR) (R44 Clinical Trial Not Allowed)- RFA-GM-19-001 R44 May 21, 2019 January 07, 2020
NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)- PAR-19-281 R34 May 15, 2019 May 14, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-19-274 R01 May 08, 2019 May 08, 2022
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-19-275 R21 May 08, 2019 May 08, 2022
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed- PA-19-270 R41/R42 May 07, 2019 April 07, 2020
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed- PA-19-272 R43/R44 May 07, 2019 April 07, 2020
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-19-041 U01 May 02, 2019 September 05, 2019
HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)- RFA-AI-19-044 U19 May 02, 2019 September 05, 2019
HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)- RFA-AI-19-045 UM1 May 01, 2019 November 19, 2019
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)- PAR-19-262 Si2/R00 May 01, 2019 August 31, 2019
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)- PAR-19-247 R21 April 11, 2019 June 19, 2021
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)- PAR-19-248 R01 April 11, 2019 June 11, 2021
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)- PAR-19-244 R25 April 09, 2019 June 05, 2021
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)- PA-19-237 R21 April 03, 2019 May 08, 2022
Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)- PAR-19-229 UH2 March 22, 2019 October 02, 2019
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)- PAR-19-209 R01 March 04, 2019 May 07, 2021